Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting publishing date : 2021 - 11 - 11 save search
WSFS Management to Hold Meetings with Investors at the D.A. Davidson Mid-Atlantic Bank Tour
Published: 2021-11-11 (Crawled : 00:00) - globenewswire.com
WSFS 4 | $45.03 0.16% 0.16% 230K
|
Finance
|
| O: 0.31%
H: 0.0%
C: 0.0%
MediciNova Announces MN-001 (tipelukast) Data regarding Lipid Metabolism in NASH/NAFLD to be Presented at The Liver Meeting® 2021, the Annual Meeting of the American Association for the Study of Liver Diseases
Published: 2021-11-11 (Crawled : 00:00) - globenewswire.com
MNOV | $1.33 -3.73% 8K
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
disease liver disease nash liver
Eyenovia to Participate in Myopia Panel Discussion at the Eyecelerator @AAO 2021 Meeting
Published: 2021-11-11 (Crawled : 19:00) - eyenoviabio.com
EYEN | $0.5897 8.68% 7.99% 770K
|
Health Technology
|
| O: 0.0%
H: 2.58%
C: -2.32%
eye
Gain Therapeutics Presents Parkinson’s Disease Preclinical Study Results at Society for Neuroscience Annual Meeting
Published: 2021-11-11 (Crawled : 17:00) - globenewswire.com
GANX | $3.16 -6.78% -7.28% 150K
|
Professional, Scientific, and T...
|
| O: 0.51%
H: 0.0%
C: -5.2%
disease results parkinson preclinical pre-clinical
Nanox to Introduce New Nanox.ARC Procedures, Highlight Nanox.AI Software Solutions at 2021 Radiology Society of North America Annual Meeting
Published: 2021-11-11 (Crawled : 15:00) - biospace.com/
NNOX | News | $9.105 -2.2% -2.25% 630K
|
Health Technology
|
| O: 1.26%
H: 0.49%
C: -2.27%
software
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 American Academy of Ophthalmology Annual Meeting
Published: 2021-11-11 (Crawled : 15:00) - biospace.com/
GKOS | $100.93 -0.17% 0.0% 520K
|
Health Technology
|
| O: -0.39%
H: 2.26%
C: 1.6%
GlycoMimetics GMI-1359 Data Selected for Presentation at 63rd American Society of Hematology (ASH) Annual Meeting and Exposition
Published: 2021-11-11 (Crawled : 15:00) - biospace.com/
GLYC | $1.855 1.09% 1.08% 660K
|
Health Technology
|
| O: 1.49%
H: 0.0%
C: -0.98%
presentation ema
Chimerix Announces Upcoming Presentations at the Society for Neuro-Oncology Annual Meeting 2021
Published: 2021-11-11 (Crawled : 15:00) - biospace.com/
CMRX | $0.9033 -2.38% -2.44% 88K
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
presentation
Lantern Pharma Announces Abstract on Effectiveness of LP-184 in Glioblastoma Accepted for Presentation at the Society for Neuro-Oncology 2021 Annual Meeting
Published: 2021-11-11 (Crawled : 14:15) - prnewswire.com
LTRN | News | $5.44 -5.72% -6.07% 96K
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
presentation glioblastoma
Second Genome Presents Preclinical Data Highlighting Potential Therapeutic Implications of Altered Gut Microbiome and Metabolites in Autism Spectrum Disorder Model and Parkinson's Disease at The Society for Neuroscience Annual Meeting
Published: 2021-11-11 (Crawled : 14:15) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.8%
H: 0.73%
C: 0.64%
disease potential parkinson preclinical pre-clinical
Aptevo Therapeutics Announces Preclinical Data for Bispecific Antibody APVO603 at the Society for Immunology in Cancer Annual Meeting
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
APVO | $0.6827 -7.27% -7.84% 570K
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
cancer antibody immunology preclinical pre-clinical
Gold Royalty Announces Town Hall Meeting - November 15, 2021
Published: 2021-11-11 (Crawled : 13:00) - prnewswire.com
GROY | News | $2.0 0.5% -0.5% 440K
|
Mining, Quarrying, and Oil and ...
|
| O: 8.89%
H: 0.15%
C: -2.6%
NanoString Launches nCounter TCR Diversity Panel and Analysis Package at the 2021 Annual Meeting of the Society for Immunotherapy of Cancer
Published: 2021-11-11 (Crawled : 12:00) - biospace.com/
NSTG M | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 4.12%
H: 5.61%
C: 5.09%
immunotherapy therapy cancer
RenovoRx Announces Presentation of Final Data from RR2 Observational Registry Study at 2021 Pancreas Club Annual Meeting
Published: 2021-11-11 (Crawled : 12:00) - biospace.com/
RNXT | $1.26 5.0% 4.76% 3.5K
|
|
| O: -7.97%
H: 17.98%
C: 13.18%
presentation pancreas gemcitabine renovogem
Everest Medicines and Gilead Sciences Jointly Announce Phase 2b Study of Sacituzumab Govitecan Conducted in China of Patients With Metastatic Triple-negative Breast Cancer Meets Primary Overall Response Rate Endpoint
Published: 2021-11-11 (Crawled : 01:00) - prnewswire.com
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.8%
H: 0.73%
C: 0.64%
phase 2 china cancer phase 2b breast cancer
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.